BridgeBio Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

BridgeBio General Information

Description

Developer of biopharmaceutical products intended for biopharmaceutical partners engaged in bispecific and multispecific antibodies. The company is engaged in the research and development of bispecific antibodies, multi-specific antibodies, and antibody-drug conjugates, thereby enabling clients to generate bispecific and multi-specific therapeutic candidates.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Room 6228, 2nd Floor, Building 6
  • Number 688 Kangqiao East Road, China (China) Pilot Free Trade Zone
  • Shanghai, 201203
  • China
Primary Industry
Biotechnology
Corporate Office
  • Room 6228, 2nd Floor, Building 6
  • Number 688 Kangqiao East Road, China (China) Pilot Free Trade Zone
  • Shanghai, 201203
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BridgeBio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BridgeBio‘s full profile, request access.

Request a free trial

BridgeBio FAQs

  • When was BridgeBio founded?

    BridgeBio was founded in 2017.

  • Where is BridgeBio headquartered?

    BridgeBio is headquartered in Shanghai, China.

  • What industry is BridgeBio in?

    BridgeBio’s primary industry is Biotechnology.

  • Is BridgeBio a private or public company?

    BridgeBio is a Private company.

  • What is the current valuation of BridgeBio?

    The current valuation of BridgeBio is .

  • What is BridgeBio’s current revenue?

    The current revenue for BridgeBio is .

  • When was BridgeBio acquired?

    BridgeBio was acquired on 28-Oct-2025.

  • Who acquired BridgeBio?

    BridgeBio was acquired by NovaBridge Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process